PIMA542306
Certolizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542306-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542306 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Certolizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
cachectin; cachexin
Immunogen
Human TNF
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
3.16 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein L
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 F(ab)
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Certolizumab is a biosimilar that targets TNF.
Compare Similar Items
Show Difference
Antigen: Certolizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: cachectin; cachexin
Immunogen: Human TNF
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.16 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein L
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 F(ab)
Antigen:
Certolizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
cachectin; cachexin
Immunogen:
Human TNF
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.16 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein L
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 F(ab)
Antigen: Brentuximab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CD30; D1S166E; Ki-1; TNFRSF8
Immunogen: Human TNFRSF8
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 4 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Brentuximab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CD30; D1S166E; Ki-1; TNFRSF8
Immunogen:
Human TNFRSF8
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
4 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1
Antigen: Talizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AL-90; C21; Hu901; HU-901; TNX-901
Immunogen: IgE
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.18 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ, IgG4 λ
Antigen:
Talizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AL-90; C21; Hu901; HU-901; TNX-901
Immunogen:
IgE
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.18 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ, IgG4 λ
Antigen: Tixagevimab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: RBD
Immunogen: SARS-CoV-2 RBD
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 1.0 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG
Antigen:
Tixagevimab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
RBD
Immunogen:
SARS-CoV-2 RBD
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
1.0 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG